ABSTRACT
Background Bladder cancer (BC) is the 10th most common cancer worldwide and ranks 13th in incidence in Ethiopia. Occupational exposure is the second leading cause of BC after smoking, accounting for 21%–27% of BC cases in men and 11% in women. This study aims to investigate the association between occupational exposure to chemical substances and bladder cancer among patients in selected hospitals in Ethiopia.
Methods A multi-center matched case-control study was conducted among patients admitted to four teaching hospitals in Addis Ababa, Ethiopia from May 01 to August 31 2023. Underlying characteristics between cases and controls were compared using Chi-square test and Mann-Whitney U test with statistical significance set at p ≤ 0.05. A multivariable binary logistic regression analysis was run where adjusted odds ratios (AOR) with 95% confidence intervals (CIs), and p-values were used for significance testing and result interpretation.
Results Among the 303 patients studied, 90 (29.7%) were cases and 213 (70.3%) were controls. Age (±5 years), sex, and smoking status were matched in 68% of participants. The majority of the participants were age 60 years and above (62.2% of cases, 59.1% of controls), male (72% of cases, 73% of controls) and non-smokers (61.1% of cases, 64.8% of controls). Occupational exposure was not found to be significantly associated with BC (AOR:1.09; 95%CI= 0.44, 2.74; P=0.85). On the other hand, having a primary level education or higher (AOR:0.12 95%CI= 0.05, 0.30; P<0.001), consuming coffee for more than 20 years (AOR:2.36; 95% CI=1.22, 4.56; P=0.01) and regular analgesics use (AOR: 6.60; 95% CI=3.34, 13.02; p<0.001) were found to be significantly associated with BC.
Conclusions Occupational exposure to chemical substances was not found to be significantly associated with BC. However, having primary education or higher was protective, while long-term coffee consumption and regular analgesic use were significantly associated with BC. Health care professionals are advised to educate patients about safe analgesic use. Furthermore, future multicenter case-control studies should be conducted to further explore the potential associations of these factors with bladder cancer.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of the School of Public Health of GAMBY Medical and Business College, Black Lion Specialized Hospital, St. Paul Hospital, and Addis Ababa Health Bureau gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available from the corresponding author on reasonable request.
LIST OF ABBREVIATIONS
- BC
- Bladder cancer
- IARC
- International Agency for Research on Cancer
- ILO
- International Labor Organization
- NSAIDS
- Non-steroidal anti-inflammatory drugs
- OHS
- Occupational health services
- PAHs
- Polycyclic aromatic hydrocarbons
- UTI
- Urinary tract infection
